Skip to main content
LITTLE GREEN PHARMA LTD logo

LITTLE GREEN PHARMA LTD — Investor Relations & Filings

Ticker · LGP ISIN · AU0000074924 ASX Manufacturing
Open in API
Filings indexed 445 across all filing types
Latest filing 2024-10-16 Regulatory Filings
Country AU Australia
Listing ASX LGP

About LITTLE GREEN PHARMA LTD

https://www.littlegreenpharma.com/

Little Green Pharma Ltd is a vertically integrated medicinal cannabis company focused on the cultivation, production, and distribution of pharmaceutical-grade cannabis medicines. The company operates advanced cultivation and manufacturing facilities, producing a diverse range of products including oils and dried flower. Adhering to Good Manufacturing Practice (GMP) standards, it ensures product consistency and safety across its entire supply chain, from genetics and breeding to final delivery. Little Green Pharma serves both domestic and international markets, maintaining a significant presence in Europe, including Germany and the United Kingdom. The company is committed to advancing clinical research and development to support the therapeutic use of cannabis for various medical conditions, focusing on patient-centric care and high-quality delivery systems.

Recent filings

Filing Released Lang Actions
Cleansing Notice 2 pages 203.6KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 17 October 2024 by Little Green Pharma Ltd. It is titled 'Cleansing Notice' and references section 708A(5)(e) of the Corporations Act 2001. The notice informs about the application for quotation of shares issued as consideration for services, compliance with disclosure provisions, and absence of excluded information. It also mentions quarterly revenue and cash receipts figures from the September Quarterly & 4C report but does not contain detailed financial statements or substantive financial data itself. The document is relatively short (4451 characters) and serves as a regulatory announcement about share issuance and compliance rather than a full financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-10-16 English
Quarterly Activities Report and Appendix 4C 23 pages 5.4MB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Quarterly Activities Report and Appendix 4C' and contains detailed financial and operational data for the quarter ending 30 September 2024. It includes revenue figures, cash receipts, cash flow analysis, segment and product category breakdowns, and updates on operations and markets. The presence of Appendix 4C, which is a standard quarterly cash flow report required by the ASX, further confirms this is a quarterly report. The document is comprehensive and contains substantive financial data and analysis for a period shorter than a full fiscal year, consistent with an Interim / Quarterly Report. It is not merely an announcement or a brief summary, nor is it a full annual report or earnings release. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q1 2025
2024-10-16 English
Change of Director's Interest Notice x 2 5 pages 195.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by company directors, including direct and indirect interests, number of securities held before and after changes, and nature of changes such as issuance of unlisted options under a Long Term Incentive Plan. The document is a formal notification of personal share transactions by company directors. It does not contain financial statements, earnings data, or management discussion. Therefore, it fits the definition of Director's Dealing filings, which report personal share transactions by company directors and executives (insider trades).
2024-09-05 English
Notification regarding unquoted securities - LGP 7 pages 21.7KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 3G notification, which is a regulatory form used to notify the issue, conversion, or payment up of unquoted equity securities. It details the issuance of unlisted options under the company's Long Term Incentive Plan, including options issued to directors and executives. The document includes specifics such as the number of securities, exercise price, expiry date, and compliance with ASX listing rules. It is not a full financial report, earnings release, or management discussion, but rather a formal announcement of a securities issuance event. This fits the definition of a Share Issue/Capital Change announcement, as it relates to new share options being issued and changes in capital structure. Therefore, the appropriate classification is SHA (Share Issue/Capital Change). The document length and content confirm it is not merely a brief announcement or a certification, but a detailed notification of a capital change event.
2024-09-02 English
Results of Annual General Meeting 2 pages 659.0KB
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an ASX announcement dated 29 August 2024 providing the results of the Annual General Meeting (AGM) of Little Green Pharma Ltd. It details the voting outcomes on various resolutions, including director re-elections, remuneration report adoption, auditor appointment, and share issuance approvals. The content is focused on the official disclosure of shareholder voting results as required by regulatory rules (Listing Rule 3.13.2 and Corporations Act Section 251AA(2)). The document does not contain financial statements or detailed financial performance data, but rather the formal voting results from the AGM. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document length is 4263 characters, which is consistent with a detailed voting results announcement rather than a full report or presentation. Therefore, the correct classification is DVA with high confidence.
2024-08-28 English
Addendum to Notice of Annual General Meeting 15 pages 805.3KB
AGM Information Classification · 95% confidence The document is an Addendum to the Notice of Annual General Meeting (AGM) for Little Green Pharma Ltd. It supplements the original AGM Notice by adding additional resolutions related to the approval of issuing Long Term Incentive Plan (LTIP) Options to executive directors. The document includes detailed explanations of the resolutions, voting exclusions, remuneration details, and compliance with listing rules and the Corporations Act. It is clearly a notice and explanatory material for an upcoming AGM, not the AGM presentation materials themselves, nor the voting results or proxy solicitation materials. The document is focused on informing shareholders about additional resolutions to be considered at the AGM. Therefore, the document fits the category of AGM Information (AGM-R).
2024-08-07 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.